Structure-Based Virtual Screening for Novel Modulators of Human Orexin 2 Receptor with Cloud Systems and Supercomputers
暂无分享,去创建一个
Kamil Kuca | Rafael Dolezal | Michaela Melikova | Eugenie Nepovimova | K. Kuča | R. Doležal | E. Nepovimova | M. Melikova
[1] J. Topliss,et al. A manual method for applying the Hansch approach to drug design. , 1977, Journal of medicinal chemistry.
[2] Hugo Kubinyi,et al. Success Stories of Computer‐Aided Design , 2006 .
[3] Atsushi Nakagawa,et al. Orexin‐A is composed of a highly conserved C‐terminal and a specific, hydrophilic N‐terminal region, revealing the structural basis of specific recognition by the orexin‐1 receptor , 2006, Journal of peptide science : an official publication of the European Peptide Society.
[4] K. Waisser,et al. QSAR study of antimycobacterial activity of quaternary ammonium salts of piperidinylethyl esters of alkoxysubstituted phenylcarbamic acids , 2008, Folia Microbiologica.
[5] H. Rickards,et al. Narcolepsy: a review , 2011, Neuropsychiatric disease and treatment.
[6] Kwong-Sak Leung,et al. idock: A multithreaded virtual screening tool for flexible ligand docking , 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB).
[7] C S Leonard,et al. Orexin/hypocretin receptor signalling cascades , 2014, British journal of pharmacology.
[8] Kwong-Sak Leung,et al. istar: A Web Platform for Large-Scale Protein-Ligand Docking , 2014, PloS one.
[9] Edward W. Lowe,et al. Computational Methods in Drug Discovery , 2014, Pharmacological Reviews.
[10] P. Kolb,et al. Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant , 2014, Nature.
[11] Kamil Kuca,et al. Parallel Flexible Molecular Docking in Computational Chemistry on High Performance Computing Clusters , 2015, ICCCI.
[12] Philip C Biggin,et al. Discovery of the First Selective, Nonpeptidic Orexin 2 Receptor Agonists. , 2015, Journal of medicinal chemistry.